Members of the vast healthcare industry, from health plans to pharmaceutical and medical device manufacturers alike, are looking to improve service, R&D efficiency, outcomes, and quality through the application of Comparative Effectiveness Analysis (CEA). Whether seeking to determine the most effective drug to have on formulary or analyzing the impact of varying medical device usage, a CEA program can have significant impact to quality, cost, and effectiveness.

MedAssurant provides CEA solutions, which apply proven, advanced data analytics to deep clinical datasets to deliver informed insight and guidance not otherwise available in the marketplace. At their core, MedAssurant’s CEA solutions rest upon its secure, Health Insurance Portability & Accountability Act (HIPAA) compliant, clinical information datasets which span virtually all clinical data types (e.g., encounters, pharmaceutical, laboratory orders and values, DME),  patient demographic types, and geographic arenas across multiple years. To this dynamic data warehouse, MedAssurant applies its advanced medical informatics toolsets and expertise to deliver the CEA solutions sought by its clients. From analyzing the efficacy of one pharmaceutical versus another pharmaceutical within a specific region or patient demographic, to identifying the specific treatment modalities which are the most clinically and cost effective for specific patient profiles, MedAssurant’s CEA solutions yield valuable insight to improve quality of care, treatment cost efficiency, and clinical effectiveness.